Effects of a New Group of Antidiabetic Drugs in Metabolic Diseases

Effects of a New Group of Antidiabetic Drugs in Metabolic Diseases

The prevalence of type 2 diabetes mellitus (T2DM) is rising in the general population. This increase leads to higher cardiovascular risk, with cardiovascular diseases being the main cause of death in diabetic patients. New therapeutic weapons for diabetes mellitus are now available. Sodium-glucose c...

Full description

Bibliographic Details
Main Authors: Jaime Sanz-Cánovas, Michele Ricci, Lidia Cobos-Palacios, Almudena López-Sampalo, Halbert Hernández-Negrín, María Vázquez-Márquez, Juan José Mancebo-Sevilla, Elena Álvarez-Recio, María Dolores López-Carmona, Miguel Ángel Pérez-Velasco, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, Maria-Rosa Bernal-López
Format: Article
Language:English
Published: IMR Press 2023-02-01
Series:Reviews in Cardiovascular Medicine
Subjects:
sglt2 inhibitors
metabolic diseases
type 2 diabetes mellitus
Online Access:https://www.imrpress.com/journal/RCM/24/2/10.31083/j.rcm2402036

Internet

https://www.imrpress.com/journal/RCM/24/2/10.31083/j.rcm2402036

Similar Items